AI in Life Sciences: Cutting Costs & Speeding Drug Development | ft. Keith Parent

In this episode of Future-Proofed Podcast, Keith Parent, CEO of Courtsquared Group, shares how AI is transforming the pharmaceutical industry—from automating document management in clinical trials to accelerating drug development. Discover how niche AI solutions are replacing manual inefficiencies, improving accuracy, and getting life-saving treatments to patients faster.Timestamps:00:01 – Introduction to the podcast and guest Keith Parent00:50 – Keith’s background and Courtsquared Group’s mission03:20 – AI for document cross-referencing in drug compound acquisitions06:26 – Challenges of AI adoption in regulated industries08:22 – Human-in-the-loop AI for clinical trial document classification11:52 – AI as a tool for preserving expertise, not replacing jobs14:30 – Future opportunities: AI for medical writing and regulatory submissions16:24 – How AI shortens drug development timelines19:34 – Replacing offshore manual labor with AI efficiency22:20 – Democratizing AI in pharma and cross-industry lessons26:14 – Comparing AI adoption to cloud/mobile revolutionsWant to future-proof your business with AI? Courtsquared Group specializes in AI-driven solutions for life sciences, including their RegDocs 365 platform. Connect with them:Website: www.courtsquaregroup.comRegDocs 365: www.regdocs365.comReach out for collaboration or AI consulting!#AIinPharma #LifeSciences #FutureProof #DigitalTransformation #ClinicalTrials #DrugDevelopment #AIAutomation #PharmaTech #KeithParent #CourtsquaredGrouphttps://valeogrowth.com/